On Tuesday, November 2, 2021, the Antitrust Division of the U.S. Department of Justice (“DOJ”) filed a lawsuit in the U.S. District Court for the District of Columbia seeking to block an acquisition by Penguin Random House,...more
Last week was momentous for the Federal Trade Commission. First, the campaign use antitrust to reign in “Big Tech” faced a setback as the United States District Court for District of Columbia dismissed the FTC’s suit against...more
7/13/2021
/ Antitrust Provisions ,
Big Tech ,
Competition ,
Facebook ,
Federal Trade Commission (FTC) ,
FTC Act ,
Google ,
Instagram ,
Monopolization ,
Sherman Act ,
Social Media ,
WhatsApp
The Federal Trade Commission’s (“FTC”) recent winning streak in its ongoing challenges of hospital and physician mergers has, at least for now, ended in a Philadelphia U.S. district court. After six days of evidentiary...more
In the latest decision addressing antitrust liability for FRAND commitments, Judge Barbara M. G. Lynn of the Northern District of Texas dismissed a complaint from Continental Automotive Systems, Inc. (“Continental”) alleging,...more
9/18/2020
/ Anti-Competitive ,
Antitrust Violations ,
Bargaining Power ,
Breach of Contract ,
Declaratory Judgments ,
Department of Justice (DOJ) ,
Dismissal With Prejudice ,
Failure To State A Claim ,
Federal Trade Commission (FTC) ,
FRAND ,
Monopolization ,
Motion to Transfer ,
Patent Infringement ,
Patents ,
Sherman Act ,
Standard Essential Patents ,
Standing ,
Subject Matter Jurisdiction ,
Supplemental Jurisdiction ,
Unfair Competition Law (UCL)
In a reversal that came as no surprise to many observers, on Tuesday, August 11, 2020, a unanimous panel of the U.S. Court of Appeals for the Ninth Circuit reversed the decision by the U.S. District Court for the Northern...more
8/18/2020
/ Anticompetitive Behavior ,
Antitrust Violations ,
Appeals ,
Cell Phones ,
Competition ,
Federal Trade Commission (FTC) ,
FRAND ,
FTC Act ,
IP License ,
Monopolization ,
OEM ,
Patent Royalties ,
Qualcomm ,
Remand ,
Reversal ,
Sherman Act ,
Standard Essential Patents
In a recent decision in In Re Humira (Adalimumab) Antitrust Litigation, No. 19-cv-1873, Judge Shah of the Northern District of Illinois dismissed a consolidated class action complaint filed by U.S. purchasers of AbbVie Inc.’s...more
6/22/2020
/ Anti-Competitive ,
Antitrust Injuries ,
Antitrust Litigation ,
Biopharmaceutical ,
Biosimilars ,
BPCIA ,
Class Action ,
Monopolization ,
Noerr-Pennington Doctrine ,
Patent Dance ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Sherman Act ,
USPTO